Who
William T. Andrews
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Catalyst Pharmaceutical; Chief Medical Officer, Flexion Therapeutics; Chief Medical Officer, Akcea Therapeutics; Chief Medical Officer, Acer Therapeutics; Officer, Aegerion Pharmaceuticals.
In numbers
- Trades disclosed
- 34
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 5
- Companies where not an officer
- 0
- First trade
- 1 Apr 2015
- Last trade
- 15 Jul 2026
- Last filed
- 17 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jul 2026filed 17 Jul 2026 | Catalyst PharmaceuticalBiotechnology | SEC FORM 4 Code D | $73K2,309 at $31.50 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticaloption or derivative · Biotechnology | SEC FORM 4 Code D | —124,447 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticaloption or derivative · Biotechnology | SEC FORM 4 Code D | —98,652 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —124,447 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —98,652 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —12,209 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —29,776 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticaloption or derivative · Biotechnology | SEC FORM 4 Code D | —12,209 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticaloption or derivative · Biotechnology | SEC FORM 4 Code D | —29,776 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | Catalyst Pharmaceuticals | SEC FORM 4 Code D | $73K2,309 at $31.50 | filing |
| 3 Jun 2026filed 5 Jun 2026 | Catalyst PharmaceuticalBiotechnology | SEC FORM 4 Code M | —3,052 | filing |
| 3 Jun 2026filed 5 Jun 2026 | Catalyst PharmaceuticalBiotechnology | SEC FORM 4 Code F | —743 | filing |
| 3 Jun 2026filed 5 Jun 2026 | Catalyst Pharmaceuticals | SEC FORM 4 Code M | —3,052 | filing |
| 3 Jun 2026filed 5 Jun 2026 | Catalyst Pharmaceuticals | SEC FORM 4 Code F | —743 | filing |
| 20 Nov 2025filed 24 Nov 2025 | Catalyst Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —98,652 at $0.00 | filing |
| 20 Nov 2025filed 24 Nov 2025 | Catalyst Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —29,776 at $0.00 | filing |
| 3 Jun 2025filed 5 Jun 2026 | Catalyst Pharmaceuticaloption or derivative · Biotechnology | SEC FORM 4 Code M | —3,052 at $0.00 | filing |
| 3 Jun 2025filed 5 Jun 2026 | Catalyst Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —3,052 at $0.00 | filing |
| 19 Nov 2021filed 19 Nov 2021 | Flexion Therapeuticsoption or derivative | SEC FORM 4 Code D | —205,500 | filing |
| 19 Nov 2021filed 19 Nov 2021 | Flexion Therapeutics | SEC FORM 4 Code D | $291K34,250 at $8.50 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.